NM_005591.4:c.337G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_005591.4(MRE11):c.337G>A(p.Asp113Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005591.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRE11 | NM_005591.4 | c.337G>A | p.Asp113Asn | missense_variant | Exon 5 of 20 | ENST00000323929.8 | NP_005582.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151920Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249486Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 135014
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460328Hom.: 0 Cov.: 31 AF XY: 0.00000826 AC XY: 6AN XY: 726520
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151920Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74186
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.D113N variant (also known as c.337G>A), located in coding exon 4 of the MRE11A gene, results from a G to A substitution at nucleotide position 337. The aspartic acid at codon 113 is replaced by asparagine, an amino acid with highly similar properties. A similar variant that affects the same amino acid residue, p.D113G (c.338A>G), was reported in an individual who was compound heterozygous for another MRE11A variant, and had a Nijmegen breakage syndrome (NBS)-like phenotype with severe microcephaly (Matsumoto Y et al. DNA Repair (Amst.) 2011 Mar;10(3):314-21). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of p.D113N remains unclear. -
Ataxia-telangiectasia-like disorder Uncertain:1
This sequence change replaces aspartic acid with asparagine at codon 113 of the MRE11 protein (p.Asp113Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with MRE11-related conditions. ClinVar contains an entry for this variant (Variation ID: 231234). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at